Alsatinib 100mg Tablet

About

Alsatinib 100mg Tablet is an oral targeted therapy, classified as a tyrosine kinase inhibitor (TKI), designed to specifically block the activity of certain protein kinases involved in cancer cell growth and survival. By inhibiting these aberrant signaling pathways, Alsatinib effectively impedes tumor proliferation, angiogenesis, and metastasis, leading to a reduction in tumor burden and disease progression.

This medication is particularly valuable in treating cancers that exhibit specific genetic alterations or overexpression of target kinases, providing a more precise and often better-tolerated treatment option compared to traditional cytotoxic agents. Consistent adherence to the prescribed regimen and close monitoring for adverse effects are crucial for maximizing therapeutic benefits.

Uses

• Treatment of specific types of lung cancer.
• Management of advanced gastric cancer.
• Therapy for hepatocellular carcinoma.
• Treatment of certain solid tumors with specific mutations.

Directions For Use

Take orally, once daily, with or without food, as prescribed by your physician. Swallow the tablet whole; do not crush, cut, or chew.

Benefits

• Highly targeted action against cancer cells.
• Oral administration for patient convenience.
• Effective in specific molecularly defined cancers.
• Can lead to significant tumor response and disease control.
• Potentially fewer severe systemic side effects compared to chemotherapy.
• Offers a valuable option for patients with advanced disease.

Side Effects

• Fatigue and weakness
• Diarrhea
• Nausea
• Skin rash (acneiform dermatitis)
• Stomatitis (mouth sores)
• Changes in liver enzymes
• Hypertension
• Proteinuria (protein in urine)
• Thrombocytopenia (low platelet count)
• Anemia
• Peripheral edema
• Headache

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may increase the risk of liver toxicity and gastrointestinal upset.
• Pregnancy - Contraindicated during pregnancy due to potential for severe fetal harm. Women of childbearing potential must use effective contraception.
• Breastfeeding - Breastfeeding is not recommended during treatment and for a period after, as the drug may be excreted in breast milk and harm the infant.
• Liver - Use with caution in patients with hepatic impairment; dose adjustments and close monitoring of liver function are necessary.
• Kidney - Use with caution in patients with renal impairment; dose adjustments may be required based on the degree of kidney dysfunction.
• Lung - Monitor for signs of interstitial lung disease (ILD) or pneumonitis, which are rare but serious pulmonary adverse events.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.